Although we initially planned to analyze pre-dialysis patients, this was not feasible as only one study examining CKD stages 3–4 was available [32], creating an important knowledge gap regarding adiponectin’s prognostic value in earlier CKD stages. The gene discussed is ADIPOQ; the disease is chronic kidney disease.